No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccine.

Tania PilliCristina DalmiglioGilda Dalmazio Alfonso SagnellaRaffaella ForleoLucia BrilliFabio MainoCristina CiuoliMaria Grazia Castagna

Published in: European journal of endocrinology (2022)

COVID-19 mRNA vaccines were well tolerated in patients with AI. Side effects were similar to those observed in the general population, and increasing glucocorticoid replacement therapy before vaccine administration was not needed.

Keyphrases

replacement therapy
coronavirus disease
sars cov
smoking cessation
artificial intelligence
respiratory syndrome coronavirus
machine learning